Personal information

Websites & social links

Twitter
researchgate

Keywords

Multiple Myeloma, single-cell RNA sequencing, AL amyloidosis

Countries

China

Activities

Collapse all

Education and qualifications (3)

Chinese Academy of Medical Sciences & Peking Union Medical College: Beijing, CN

2021-09-01 to 2026-06-30 | Ph.D. (Institue of Hematology & Blood Diseases Hospital)
Education
Source: Self-asserted source
Jian Cui

Dana-Farber Cancer Institute: Boston, US

2024-06-01 to 2025-12-31 | Graduate Student (Medical Oncology)
Education
Source: Self-asserted source
Jian Cui

Sichuan University: Chengdu, CN

2016-09-01 to 2021-06-30 | MBBS
Education
Source: Self-asserted source
Jian Cui

Funding (2)

China National Scholarship

2023-10 to 2023-10 | Award
Ministry of Education of the People's Republic of China (Beijing, CN)
Source: Self-asserted source
Jian Cui

Young Investigator Award

2023-09 to 2023-09 | Award
International Myeloma Society (MA, MA, US)
Source: Self-asserted source
Jian Cui

Works (14)

Clinical implications of residual normal plasma cells within bone marrow across various disease stages in multiple myeloma

Leukemia
2024-10 | Journal article
DOI: 10.1038/s41375-024-02366-9
Contributors: Wenqiang Yan; Lihui Shi; Jingyu Xu; Lingna Li; Jian Cui; Yuntong Liu; Jieqiong Zhou; Chenxing Du; Tengteng Yu; Shuaishuai Zhang et al.
Source: check_circle
Crossref

Data from Identification of Therapy-Induced Clonal Evolution and Resistance Pathways in Minimal Residual Clones in Multiple Myeloma through Single-Cell Sequencing

2024-09-03 | Preprint
DOI: 10.1158/1078-0432.c.7429501
Contributors: Jian Cui; Xiaoyun Li; Shuhui Deng; Chenxing Du; Huishou Fan; Wenqiang Yan; Jingyu Xu; Xiaoqing Li; Tengteng Yu; Shuaishuai Zhang et al.
Source: check_circle
Crossref

Data from Identification of Therapy-Induced Clonal Evolution and Resistance Pathways in Minimal Residual Clones in Multiple Myeloma through Single-Cell Sequencing

2024-09-03 | Preprint
DOI: 10.1158/1078-0432.c.7429501.v1
Contributors: Jian Cui; Xiaoyun Li; Shuhui Deng; Chenxing Du; Huishou Fan; Wenqiang Yan; Jingyu Xu; Xiaoqing Li; Tengteng Yu; Shuaishuai Zhang et al.
Source: check_circle
Crossref

Identification of Therapy-Induced Clonal Evolution and Resistance Pathways in Minimal Residual Clones in Multiple Myeloma through Single-Cell Sequencing

Clinical Cancer Research
2024-09-03 | Journal article
DOI: 10.1158/1078-0432.CCR-24-0545
Contributors: Jian Cui; Xiaoyun Li; Shuhui Deng; Chenxing Du; Huishou Fan; Wenqiang Yan; Jingyu Xu; Xiaoqing Li; Tengteng Yu; Shuaishuai Zhang et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Supplementary Data 1 from Identification of Therapy-Induced Clonal Evolution and Resistance Pathways in Minimal Residual Clones in Multiple Myeloma through Single-Cell Sequencing

2024-09-03 | Preprint
DOI: 10.1158/1078-0432.26926594
Contributors: Jian Cui; Xiaoyun Li; Shuhui Deng; Chenxing Du; Huishou Fan; Wenqiang Yan; Jingyu Xu; Xiaoqing Li; Tengteng Yu; Shuaishuai Zhang et al.
Source: check_circle
Crossref

Supplementary Data 1 from Identification of Therapy-Induced Clonal Evolution and Resistance Pathways in Minimal Residual Clones in Multiple Myeloma through Single-Cell Sequencing

2024-09-03 | Preprint
DOI: 10.1158/1078-0432.26926594.v1
Contributors: Jian Cui; Xiaoyun Li; Shuhui Deng; Chenxing Du; Huishou Fan; Wenqiang Yan; Jingyu Xu; Xiaoqing Li; Tengteng Yu; Shuaishuai Zhang et al.
Source: check_circle
Crossref

Supplementary Data 2 from Identification of Therapy-Induced Clonal Evolution and Resistance Pathways in Minimal Residual Clones in Multiple Myeloma through Single-Cell Sequencing

2024-09-03 | Preprint
DOI: 10.1158/1078-0432.26926591
Contributors: Jian Cui; Xiaoyun Li; Shuhui Deng; Chenxing Du; Huishou Fan; Wenqiang Yan; Jingyu Xu; Xiaoqing Li; Tengteng Yu; Shuaishuai Zhang et al.
Source: check_circle
Crossref

Supplementary Data 2 from Identification of Therapy-Induced Clonal Evolution and Resistance Pathways in Minimal Residual Clones in Multiple Myeloma through Single-Cell Sequencing

2024-09-03 | Preprint
DOI: 10.1158/1078-0432.26926591.v1
Contributors: Jian Cui; Xiaoyun Li; Shuhui Deng; Chenxing Du; Huishou Fan; Wenqiang Yan; Jingyu Xu; Xiaoqing Li; Tengteng Yu; Shuaishuai Zhang et al.
Source: check_circle
Crossref

Fluorescence in situ hybridization reveals the evolutionary biology of minor clone of gain/amp(1q) in multiple myeloma

Leukemia
2024-06 | Journal article
DOI: 10.1038/s41375-024-02237-3
Contributors: Jian Cui; Yuntong Liu; Rui Lv; Wenqiang Yan; Jingyu Xu; Lingna Li; Chenxing Du; Tengteng Yu; Shuaishuai Zhang; Shuhui Deng et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Minor clone of del(17p) provides a reservoir for relapse in multiple myeloma.

Haematologica
2024-02-01 | Journal article
DOI: 10.3324/haematol.2023.283533
PMID: 37534514
Contributors: Cui J; Lv R; Yu T; Yan W; Xu J; Fan H; Li L; Liu Y; Du C; Deng S et al.
Source: Self-asserted source
Jian Cui

Longitudinal genetically detectable minimal residual disease by fluorescence in situ hybridization confers a poor prognosis in myeloma.

Therapeutic advances in medical oncology
2024-01-19 | Journal article | Author
DOI: 10.1177/17588359231221340
PMID: 38249329
PMC: PMC10799601
Contributors: Jian Cui; Yu T; Lv R; Liu J; Fan H; Yan W; Xu J; Du C; Deng S; Sui W et al.
Source: Self-asserted source
Jian Cui
grade
Preferred source (of 2)‎

Challenges for CAR-T cell therapy in multiple myeloma: overcoming the tumor microenvironment

Hematology and Oncology Discovery
2023 | Journal article
DOI: 10.15212/hod-2022-0008
Part of ISSN: 2811-5619
Contributors: Jian Cui; Gang An; Lugui Qiu
Source: Self-asserted source
Jian Cui

Predictive Values of PET/CT in Combination With Regulatory B Cells for Therapeutic Response and Survival in Contemporary Patients With Newly Diagnosed Multiple Myeloma.

Frontiers in immunology
2021-08-19 | Journal article
DOI: 10.3389/fimmu.2021.671904
PMID: 34489930
PMC: PMC8417409
Contributors: Cui J; Zou Z; Duan J; Tang W; Li Y; Zhang L; Pan L; Niu T
Source: Self-asserted source
Jian Cui

Does percutaneous transthoracic needle biopsy increase the risk of pleural recurrence in patients with stage I lung cancer?

Interactive CardioVascular and Thoracic Surgery
2020-06-01 | Journal article
DOI: 10.1093/icvts/ivaa027
Contributors: Diou Cheng; Zihuai Wang; Jian Cui; Lunxu Liu
Source: check_circle
Crossref
How many people are using ORCID?